184 related articles for article (PubMed ID: 21674413)
21. Antineutrophil cytoplasmic antibody-associated vasculitis in Taiwan: A hospital-based study with reference to the population-based National Health Insurance database.
Wu CS; Hsieh CJ; Peng YS; Chang TH; Wu ZY
J Microbiol Immunol Infect; 2015 Oct; 48(5):477-82. PubMed ID: 24560699
[TBL] [Abstract][Full Text] [Related]
22. The lung in systemic vasculitis.
Leatherman JW
Semin Respir Infect; 1988 Sep; 3(3):274-88. PubMed ID: 2903521
[TBL] [Abstract][Full Text] [Related]
23. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.
Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J
Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795
[TBL] [Abstract][Full Text] [Related]
24. Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis.
Casian A; Jayne D
Curr Opin Rheumatol; 2011 Jan; 23(1):12-7. PubMed ID: 21124082
[TBL] [Abstract][Full Text] [Related]
25. ANCA vasculitis: to lump or split? Why we should study MPA and GPA separately.
Watts RA; Scott DG
Rheumatology (Oxford); 2012 Dec; 51(12):2115-7. PubMed ID: 22923757
[No Abstract] [Full Text] [Related]
26. Microscopic polyangiitis (microscopic polyarteritis).
Jennette JC; Thomas DB; Falk RJ
Semin Diagn Pathol; 2001 Feb; 18(1):3-13. PubMed ID: 11296991
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome.
Sinico RA; Di Toma L; Maggiore U; Bottero P; Radice A; Tosoni C; Grasselli C; Pavone L; Gregorini G; Monti S; Frassi M; Vecchio F; Corace C; Venegoni E; Buzio C
Arthritis Rheum; 2005 Sep; 52(9):2926-35. PubMed ID: 16142760
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides.
Kallenberg CG; Heeringa P; Stegeman CA
Nat Clin Pract Rheumatol; 2006 Dec; 2(12):661-70. PubMed ID: 17133251
[TBL] [Abstract][Full Text] [Related]
29. Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment.
Lynch JP; Tazelaar H
Semin Respir Crit Care Med; 2011 Jun; 32(3):274-97. PubMed ID: 21674414
[TBL] [Abstract][Full Text] [Related]
30. Outcome and prognostic factors during the course of primary small-vessel vasculitides.
Pavone L; Grasselli C; Chierici E; Maggiore U; Garini G; Ronda N; Manganelli P; Pesci A; Rioda WT; Tumiati B; Pavesi G; Vaglio A; Buzio C;
J Rheumatol; 2006 Jul; 33(7):1299-306. PubMed ID: 16783858
[TBL] [Abstract][Full Text] [Related]
31. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.
Wieczorek S; Hellmich B; Arning L; Moosig F; Lamprecht P; Gross WL; Epplen JT
Arthritis Rheum; 2008 Jun; 58(6):1839-48. PubMed ID: 18512809
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one 'anti-neutrophil cytoplasm antibodies-associated vasculitis' entity?
Mahr AD
APMIS Suppl; 2009 Jun; (127):41-7. PubMed ID: 19515139
[TBL] [Abstract][Full Text] [Related]
33. [ANCA-associated vasculitis (Wegener's granulomatosis, Churg-Strauss syndrome, microscopic polyangiitis). 2. Diagnostic procedure].
de Groot K; Schnabel A; Gross WL
Z Rheumatol; 1995; 54(5):291-302. PubMed ID: 8578885
[TBL] [Abstract][Full Text] [Related]
34. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort.
Guillevin L; Pagnoux C; Seror R; Mahr A; Mouthon L; Toumelin PL;
Medicine (Baltimore); 2011 Jan; 90(1):19-27. PubMed ID: 21200183
[TBL] [Abstract][Full Text] [Related]
35. Tobacco differentially affects the clinical-biological phenotypes of ANCA-associated vasculitides.
Benarous L; Terrier B; Puéchal X; Dunogué B; Cohen P; Le Jeunne C; Mouthon L; Guillevin L;
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-116-21. PubMed ID: 26016761
[TBL] [Abstract][Full Text] [Related]
36. [Pleuropulmonary manifestations of necrotising vasculitis].
Defuentes G; Cremades S; Carmoi T; Ficko C; Mangouka L; Dutasta F; Nielly H; Margery J; Berets O
Rev Pneumol Clin; 2010 Oct; 66(5):295-301. PubMed ID: 21087724
[TBL] [Abstract][Full Text] [Related]
37. Improved differentiation between Churg-Strauss syndrome and Wegener's granulomatosis by an artificial neural network.
Schmitt WH; Linder R; Reinhold-Keller E; Gross WL
Arthritis Rheum; 2001 Aug; 44(8):1887-96. PubMed ID: 11508442
[TBL] [Abstract][Full Text] [Related]
38. A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis.
Suppiah R; Mukhtyar C; Flossmann O; Alberici F; Baslund B; Batra R; Brown D; Holle J; Hruskova Z; Jayne DR; Judge A; Little MA; Palmisano A; Stegeman C; Tesar V; Vaglio A; Westman K; Luqmani R
Rheumatology (Oxford); 2011 May; 50(5):899-905. PubMed ID: 21156667
[TBL] [Abstract][Full Text] [Related]
39. Advances in the treatment of small vessel vasculitis.
Molloy ES; Langford CA
Rheum Dis Clin North Am; 2006 Feb; 32(1):157-72, x. PubMed ID: 16504828
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary vasculitis.
Lally L; Spiera RF
Rheum Dis Clin North Am; 2015 May; 41(2):315-31. PubMed ID: 25836645
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
